SCOPUS 정보 검색 플랫폼

Lancet

Volumn 367, Issue 9522, 2006, Pages 1571-

Antivirals for influenza in healthy adults

(3) Smith, James a Dutkowski, Regina b Ward, Penelope c

a F HOFFMANN LA ROCHE LTD (Switzerland)

b HOFFMANN LA ROCHE INC (United States)

c ROCHE PRODUCTS LTD (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; PLACEBO; SIALIDASE INHIBITOR; ENZYME INHIBITOR; SIALIDASE; ANTIVIRUS AGENT; ZANAMIVIR;

ANTIBIOTIC PROPHYLAXIS; DISEASE SEVERITY; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; LETTER; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT INDICATION; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS STRAIN; ADULT; AGED; CHILD; DRUG ANTAGONISM; DRUG EFFECT; NOTE; VIROLOGY; INFLUENZA VIRUS A H5N1; PATHOGENICITY; DRUG EFFICACY; PROPHYLAXIS;

ADULT; AGED; CHILD; ENZYME INHIBITORS; HUMANS; INFLUENZA, HUMAN; NEURAMINIDASE; VIRUS REPLICATION; ANTIVIRAL AGENTS; INFLUENZA A VIRUS, H5N1 SUBTYPE;

EID: 33646363782 PISSN: 01406736 EISSN: None Source Type: Journal
DOI: 10.1016/S0140-6736(06)68683-2 Document Type: Letter

Times cited : (9)

References (5)

1
- 31444436460
- Antivirals for influenza in healthy adults: systematic review
- Jefferson T., Demicheli V., Rivetti D., Jones M., Di Pietrantonj C., and Rivetti A. Antivirals for influenza in healthy adults: systematic review. Lancet 367 (2006) 303-313
- (2006) Lancet , vol.367 , pp. 303-313
- Jefferson, T.¹ Demicheli, V.² Rivetti, D.³ Jones, M.⁴ Di Pietrantonj, C.⁵ Rivetti, A.⁶

2
- 18144394370
- Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance
- McKimm-Breschkin J. Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance. Treat Respir Med 4 (2005) 107
- (2005) Treat Respir Med , vol.4 , pp. 107
- McKimm-Breschkin, J.¹

3
- 0033530264
- Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment
- Hayden F., Treanor J., Fritz R., et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 282 (1999) 1240
- (1999) JAMA , vol.282 , pp. 1240
- Hayden, F.¹ Treanor, J.² Fritz, R.³

4
- 0034722740
- Clinical signs and symptoms predicting influenza infection
- Monto A., Gravenstein S., Elliott M., Colopy M., and Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med 160 (2000) 3243
- (2000) Arch Intern Med , vol.160 , pp. 3243
- Monto, A.¹ Gravenstein, S.² Elliott, M.³ Colopy, M.⁴ Schweinle, J.⁵

5
- 23244456655
- Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic a/vietnam/1203/04 influenza virus in mice
- Yen H., Monto A., Webster R., and Govorkova E. Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic a/vietnam/1203/04 influenza virus in mice. J Infect Dis 192 (2005) 665
- (2005) J Infect Dis , vol.192 , pp. 665
- Yen, H.¹ Monto, A.² Webster, R.³ Govorkova, E.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.